These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 35753728

  • 1. Oxalate crystal-related acute renal injury caused by orlistat: A case report.
    Cui X, Chen X, Li Y, Fu X, Song P, Xiao L, Sun L, Liu H, Zhu X, Yuan S.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May 28; 47(5):583-587. PubMed ID: 35753728
    [Abstract] [Full Text] [Related]

  • 2. A hidden cause of oxalate nephropathy: a case report.
    Mahmoud T, Ghandour EC, Jaar BG.
    J Med Case Rep; 2021 Mar 08; 15(1):106. PubMed ID: 33678172
    [Abstract] [Full Text] [Related]

  • 3. When the Cause Is Not Crystal Clear.
    Forryan J, Mishra V, Gibbons E.
    N Engl J Med; 2020 Jan 02; 382(1):74-78. PubMed ID: 31893519
    [No Abstract] [Full Text] [Related]

  • 4. Purslane-induced oxalate nephropathy: case report and literature review.
    Wang X, Zhang X, Wang L, Zhang R, Zhang Y, Cao L.
    BMC Nephrol; 2023 Jul 13; 24(1):207. PubMed ID: 37443012
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic insufficiency as a complication of type 1 diabetes causing enteric hyperoxaluria in a transplant kidney.
    Chambers J, Appleton A, Dudley C.
    BMJ Case Rep; 2022 Jul 04; 15(7):. PubMed ID: 35787489
    [Abstract] [Full Text] [Related]

  • 6. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
    Ligon CB, Hummers LK, McMahan ZH.
    Semin Arthritis Rheum; 2015 Dec 04; 45(3):315-20. PubMed ID: 26239907
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxalate nephropathy due to 'juicing': case report and review.
    Getting JE, Gregoire JR, Phul A, Kasten MJ.
    Am J Med; 2013 Sep 04; 126(9):768-72. PubMed ID: 23830537
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review.
    Demoulin N, Aydin S, Gillion V, Morelle J, Jadoul M.
    Am J Kidney Dis; 2022 May 04; 79(5):717-727. PubMed ID: 34508834
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Secondary hyperoxaluria due to pancreatic insufficiency.
    de Martines DGL, Gianotten S, F M Wetzels J, G van der Meijden WA.
    Neth J Med; 2019 Oct 04; 77(8):287-292. PubMed ID: 31814577
    [Abstract] [Full Text] [Related]

  • 19. Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.
    Kwan TK, Chadban SJ, McKenzie PR, Saunders JR.
    Nephrology (Carlton); 2013 Mar 04; 18(3):241-2. PubMed ID: 23432752
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.